291 related articles for article (PubMed ID: 34641434)
1. Effects of Wine Components in Inflammatory Bowel Diseases.
Vrdoljak J; Kumric M; Ticinovic Kurir T; Males I; Martinovic D; Vilovic M; Bozic J
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641434
[TBL] [Abstract][Full Text] [Related]
2. Effects of Olive Oil and Its Components on Intestinal Inflammation and Inflammatory Bowel Disease.
Vrdoljak J; Kumric M; Vilovic M; Martinovic D; Tomic IJ; Krnic M; Ticinovic Kurir T; Bozic J
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215407
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol and inflammatory bowel disease: the evidence so far.
Nunes S; Danesi F; Del Rio D; Silva P
Nutr Res Rev; 2018 Jun; 31(1):85-97. PubMed ID: 29191255
[TBL] [Abstract][Full Text] [Related]
4. Is moderate red wine consumption safe in inactive inflammatory bowel disease?
Swanson GR; Tieu V; Shaikh M; Forsyth C; Keshavarzian A
Digestion; 2011; 84(3):238-44. PubMed ID: 21876358
[TBL] [Abstract][Full Text] [Related]
5. Intestinal anti-inflammatory activity of red wine extract: unveiling the mechanisms in colonic epithelial cells.
Nunes C; Ferreira E; Freitas V; Almeida L; Barbosa RM; Laranjinha J
Food Funct; 2013 Feb; 4(3):373-83. PubMed ID: 23233037
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol and resveratrol nano-delivery systems in the treatment of inflammatory bowel disease.
Gowd V; Kanika ; Jori C; Chaudhary AA; Rudayni HA; Rashid S; Khan R
J Nutr Biochem; 2022 Nov; 109():109101. PubMed ID: 35777588
[TBL] [Abstract][Full Text] [Related]
7. [Polyphenols in the treatment of inflammatory bowel diseases].
Chojnacka K; Laskowska J
Postepy Biochem; 2020 Sep; 66(3):256-262. PubMed ID: 33315320
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn?
O'Sullivan M
Proc Nutr Soc; 2015 Feb; 74(1):5-12. PubMed ID: 25490986
[TBL] [Abstract][Full Text] [Related]
9. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
10. Potential role of nutraceutical compounds in inflammatory bowel disease.
Larussa T; Imeneo M; Luzza F
World J Gastroenterol; 2017 Apr; 23(14):2483-2492. PubMed ID: 28465632
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory Effects of Flavonoids in the Prophylaxis and Treatment of Inflammatory Bowel Diseases: A Comprehensive Review.
Ribeiro D; Proenca C; Rocha S; Lima JLFC; Carvalho F; Fernandes E; Freitas M
Curr Med Chem; 2018; 25(28):3374-3412. PubMed ID: 29446723
[TBL] [Abstract][Full Text] [Related]
12. Repurposing metformin as a potential treatment for inflammatory bowel disease: Evidence from cell to the clinic.
Wanchaitanawong W; Thinrungroj N; Chattipakorn SC; Chattipakorn N; Shinlapawittayatorn K
Int Immunopharmacol; 2022 Nov; 112():109230. PubMed ID: 36099786
[TBL] [Abstract][Full Text] [Related]
13. NLRP3 Inhibitors as Potential Therapeutic Agents for Treatment of Inflammatory Bowel Disease.
Perera AP; Kunde D; Eri R
Curr Pharm Des; 2017; 23(16):2321-2327. PubMed ID: 28155620
[TBL] [Abstract][Full Text] [Related]
14. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
15. Review of Saccharomyces boulardii as a treatment option in IBD.
Sivananthan K; Petersen AM
Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
[TBL] [Abstract][Full Text] [Related]
16.
Musumeci L; Maugeri A; Cirmi S; Lombardo GE; Russo C; Gangemi S; Calapai G; Navarra M
Nat Prod Res; 2020 Jan; 34(1):122-136. PubMed ID: 30990326
[TBL] [Abstract][Full Text] [Related]
17. Red wine polyphenolics reduce the expression of inflammation markers in human colon-derived CCD-18Co myofibroblast cells: potential role of microRNA-126.
Angel-Morales G; Noratto G; Mertens-Talcott S
Food Funct; 2012 Jul; 3(7):745-52. PubMed ID: 22572890
[TBL] [Abstract][Full Text] [Related]
18. Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association.
Principi M; Cassano N; Contaldo A; Iannone A; Losurdo G; Barone M; Mastrolonardo M; Vena GA; Ierardi E; Di Leo A
World J Gastroenterol; 2016 May; 22(20):4802-11. PubMed ID: 27239107
[TBL] [Abstract][Full Text] [Related]
19. Phytochemical drug candidates for the modulation of peroxisome proliferator-activated receptor γ in inflammatory bowel diseases.
Venkataraman B; Ojha S; Belur PD; Bhongade B; Raj V; Collin PD; Adrian TE; Subramanya SB
Phytother Res; 2020 Jul; 34(7):1530-1549. PubMed ID: 32009281
[TBL] [Abstract][Full Text] [Related]
20. Food and Food Groups in Inflammatory Bowel Disease (IBD): The Design of the Groningen Anti-Inflammatory Diet (GrAID).
Campmans-Kuijpers MJE; Dijkstra G
Nutrients; 2021 Mar; 13(4):. PubMed ID: 33806061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
